Tenovin-1
CAS No. 380315-80-0
Tenovin-1 ( Tenovin 1 )
Catalog No. M14310 CAS No. 380315-80-0
Tenovin-1 (Tenovin1) is a small molecules that activate p53 and decreases tumor growth through inhibition of the protein-deacetylating activities of SirT1 and SirT2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 45 | In Stock |
|
25MG | 68 | In Stock |
|
50MG | 101 | In Stock |
|
100MG | 182 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTenovin-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionTenovin-1 (Tenovin1) is a small molecules that activate p53 and decreases tumor growth through inhibition of the protein-deacetylating activities of SirT1 and SirT2.
-
DescriptionTenovin-1 (Tenovin1) is a small molecules that activate p53 and decreases tumor growth through inhibition of the protein-deacetylating activities of SirT1 and SirT2; causes significantly greater growth inhibition, cell death via apoptosis, as well as superior p53 promoter upregulation in wtp53 MyLa cells when combined with vorinostat; elicits caspase-mediated cell death in p53 wild-type cells, but caspase-independent cell death in p53 null cells.
-
SynonymsTenovin 1
-
PathwayChromatin/Epigenetic
-
TargetSirtuin
-
RecptorMdm2;p53
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number380315-80-0
-
Formula Weight369.48
-
Molecular FormulaC20H23N3O2S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC(NC1=CC=C(NC(C)=O)C=C1)=S)C2=CC=C(C(C)(C)C)C=C2
-
Chemical NameBenzamide, N-[[[4-(acetylamino)phenyl]amino]thioxomethyl]-4-(1,1-dimethylethyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lain S, et al. Cancer Cell. 2008 May;13(5):454-63.
2. Sonnemann J, et al. Br J Cancer. 2014 Feb 4;110(3):656-67.
3. Nihal M, et al. Cell Cycle. 2014;13(4):632-40. doi: 10.4161/cc.27523.
4. Marx C, et al. Invest New Drugs. 2018 Jun;36(3):396-406.
2. Sonnemann J, et al. Br J Cancer. 2014 Feb 4;110(3):656-67.
3. Nihal M, et al. Cell Cycle. 2014;13(4):632-40. doi: 10.4161/cc.27523.
4. Marx C, et al. Invest New Drugs. 2018 Jun;36(3):396-406.
molnova catalog